June 29, 2026
1 min read

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster

Sobi’s plan to introduce a challenger to Amgen’s blockbuster gout drug Krystexxa has been put on hold by the FDA.

Leave a Reply

Your email address will not be published.

Previous Story

Fertility Preservation Often Overlooked In Women’s Cancer Care, Review Finds MedNews

Next Story

Everyone is buying it instead of milk, but it provides almost zero protein

Previous Story

Fertility Preservation Often Overlooked In Women’s Cancer Care, Review Finds MedNews

Next Story

Everyone is buying it instead of milk, but it provides almost zero protein

Latest from Blog

Go toTop